Drugs / IFN
last change Apr 2017 re-read 2 minutes ago

IFN

Developed for
colorectal carcinoma
Investigated by
AIM ImmunoTech Inc. · Roswell Park Cancer Institute

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01545141 Oct 2012 → Apr 2016 colorectal carcinoma Roswell Park Cancer Institute Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IFN IFN: i.v. administration, M-F of the week prior to scheduled surgery. Dose escalation evaluating 5, 10, and 20 MU/m2.” NCT01545141
Route Intravenous “IFN by intravenous infusion (IV)” NCT01545141